PharmEasy acquires Aknamed in $180-$190 million stock deal - Business News: Latest News & Videos about market and economy | Trendmergers

Breaking

Post Top Ad

Post Top Ad

PharmEasy acquires Aknamed in $180-$190 million stock deal

The acquisition, which is similar to its purchase of Thyrocare in June, is part of the Mumbai-based company’s plans to position itself as a broader online healthcare firm, diversifying from being just an online medicine delivery platform.

from Industry-Economic Times
Read The Rest:economictimes...

Post Top Ad